Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
- Status
- COMPLETED
- Phase
- PHASE4
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE4
ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
- Status
- COMPLETED
- Phase
- NA
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Dapagliflozin on Inflammation and Endothelial Function
- Status
- TERMINATED
- Phase
- PHASE4
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
- Status
- COMPLETED
- Phase
- PHASE3
Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
- Status
- UNKNOWN
- Phase
- PHASE4
Foxiga Korea Local Phase 4 Study
- Status
- COMPLETED
- Phase
- PHASE4
Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
- Status
- COMPLETED
- Phase
- PHASE3
Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?
- Status
- TERMINATED
- Phase
- PHASE2
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Dapagliflozine on Systemic and Renal Endothelial Function
- Status
- UNKNOWN
- Phase
- PHASE4
Vildagliptin Versus Dapagliflozin on Glucagon
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3